Back
Immunome Stock Predictions
Sponsored
IMNM
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
48
IMNM
Immunome
Last Price:
12.96
Seasonality Move:
24.43%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeImmunome Stock Forecast
- Over the next 52 weeks, Immunome has on average historically risen by 39.2% based on the past 4 years of stock performance.
- Immunome has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Immunome Stock Undervalued?
The current Immunome [IMNM] share price is $12.97. The Score for IMNM is 48, which is 4% below its historic median score of 50, and infers higher risk than normal. - IMNM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Immunome Stock Go Up Next Year?
- Over the next 52 weeks, Immunome has on average historically risen by 39.2% based on the past 4 years of stock performance.
Immunome Stock Rating
Sell
48
Immunome (IMNM)
is a Sell
Is Immunome overpriced?
- Immunome has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Immunome Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunome.com
52-Week Data
52-Week High:
30.96
52-Week Low:
6.93
Prediction Charts
Market Cap:
778.91M
Price in USD:
12.97
Volume:
414.8K
Beta:
1.83
Technical Analysis
SMA50:
13.60
SMA100:
13.61
SMA200:
16.40
52-Wk Change:
48.23%
Stock Predictions
-
Is Immunome stock public?
Yes, Immunome is a publicly traded company. -
What is the Immunome stock quote today?
The Immunome stock price is 12.97 USD today. -
How to buy Immunome stock online?
You can buy Immunome shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-16 | 12.28 | 12.34 | 12.38 | 11.85 |
Oct-18 | 12.24 | 12.28 | 12.46 | 12.08 |
Oct-21 | 12.23 | 11.91 | 12.36 | 11.80 |
Oct-22 | 11.82 | 11.71 | 11.91 | 11.36 |
Oct-23 | 11.64 | 11.60 | 11.91 | 11.33 |
Oct-24 | 11.73 | 12.01 | 12.06 | 11.64 |
Oct-25 | 12.10 | 12.11 | 12.65 | 11.91 |
Oct-28 | 12.34 | 12.41 | 12.72 | 12.17 |
Oct-29 | 12.47 | 12.19 | 12.47 | 11.93 |
Oct-30 | 12.06 | 12.22 | 12.42 | 11.90 |
Oct-31 | 12.07 | 11.46 | 12.08 | 11.43 |
Nov-1 | 11.81 | 11.59 | 11.92 | 11.48 |
Nov-4 | 11.52 | 12.82 | 12.86 | 11.40 |
Nov-5 | 12.78 | 12.97 | 13.00 | 12.50 |
Immunome Earnings
Immunome Earnings Report: Per Share Immunome Earnings Q1 Q2 Q3 and Q4 last year and next year.
Immunome Forecast Revenue Growth
Immunome Stock Analysis: Historical quarterly revenues per share for Immunome and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.86 per share, and an increase next year of $1.14 per share.
* Immunome stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.